THRIVE: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of Veligrotug for Active Thyroid Eye Disease. Yen MT, Cockerham K, Saeed P, Leibowitz S, et al. Ophthalmology 2026;133:1085-1096.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yen MT, Cockerham K, Saeed P, Leibowitz S, et al. THRIVE: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of Veligrotug for Active Thyroid Eye Disease. Ophthalmology 2026;133:1085-1096.
PMID: 42223386